GlassScriptPhysician profile
Haroon Ilyas Rasheed
NPI 1285639096
$5,132.30
in general payments reported to CMS, 2019-2025
26 companies · $456 in 2025
The $456 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $851 · 2021: $959 · 2022: $688 · 2023: $401 · 2024: $1,089 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,944 · Travel and Lodging: $1.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.98 |
| Travel and Lodging | $1.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $832.58 | 2019-2024 | Eterna |
| Medtronic, INC. | $813.11 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $620.78 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Biohaven Pharmaceuticals, INC. | $353.36 | 2020-2021 | |
| Medtronic USA, INC. | $296.28 | 2020 | |
| Nalu Medical, INC. | $202.54 | 2020 | |
| Redhill Biopharma INC. | $195.49 | 2021 | |
| Nevro Corp. | $187.27 | 2024 | Senza |
| Spinal Simplicity, LLC | $182.27 | 2024-2025 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $163.65 | 2022 | |
| Vertos Medical, INC. | $141.84 | 2022 | |
| Forte Bio-Pharma LLC | $140.54 | 2025 | Prolate, Nalocet, Tanlor |
| Averitas Pharma INC. | $136.91 | 2024 | Qutenza |
| Curonix LLC | $130.39 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.55 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $110.74 | 2019 | |
| Brainsway USA INC | $110.15 | 2022 | |
| Abbvie INC. | $104.87 | 2021-2023 | |
| Pfizer INC. | $102.60 | 2024 | |
| Biodelivery Sciences International, INC. | $76.42 | 2021 | |
| Bioventus LLC | $46.09 | 2024 | Supartz Fx Sodium Hyaluronate, Durolane |
| Allergan, INC. | $15.69 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.37 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.34 | 2025 | |
| Horizon Therapeutics Plc | $14.25 | 2020 | |
| Electronic Waveform Lab, INC. | $10.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haroon Rasheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.